Anticoagulants 1 Flashcards
Heparin MOA Route of administration Indication Adverse Effects
MOA
Complex with AT and inhibit factors 10a and 2a. Monitored by APTT(2-2.5)
Route of Administration
Mainly IV
Also subcutaneous
Indication:
Surgical Anticoagulation
Adverse Effects:
- Bleeding
- HIT
- Osteoporosis
- Alopecia
Low Molecular Weight Heparins
MOA
Complex with AT and inhibits factors 10a and 2a-monitored by 10a
Route
Subcutaneous
Indication:
Prophylaxis and Treatment of DVT and ACS
Adverse:
Bleeding
Fondaparinux
Pentasaccharide
MOA
Complex with AT and inhibit 10a
Route
Subcutaneous
Indication:
DVT
Adverse:
Bleeding
Argatroban/Bivalirudin/Hirudin
MOA
Directly inhibits 2a
Route
IV
Indication:
HIT
Adverse:
Bleeding
Antithrombin Concentrate
MOA
Directly inhibits 2a
Route:
IV
Indication:
DIC, sepsis, thrombophilia, hypercoagulable state
No adverse
Protamine Sulfate
MOA
Heparin antagonist
Route
IV
Indication:
Reversal for Heparin
Adverse:
- Bradycardia
- Hypotension